Mycobacterium malmoense--report of a case in Switzerland.
Mycobacterium malmoense was isolated in four different sputum samples of a 45-year-old alcoholic smoker. The biochemical and culture characteristics of this species are described and compared with a reference strain (ATCC 29571). The isolated strain was sensitive in vitro to rifampicine, ethionamide, kanamycine and erythromycin. Therapy consisted of right-upper-lobe lobectomy and a two-year antimicrobial therapy. There was no sign of relapse at the end of the treatment period.
Leuenberger
P
P
Department of Internal Medicine, University of Lausanne, Medical School, Switzerland.
Aubert
J D
JD
Beer
V
V
D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009161:Mycobacterium / Q000302:isolation & purification*; D009164:Mycobacterium Infections / Q000209:etiology*; D009165:Mycobacterium Infections, Nontuberculous / Q000209:etiology* / Q000628:therapy; D009170:Nontuberculous Mycobacteria / Q000187:drug effects / Q000302:isolation & purification*; D011013:Pneumonectomy; D012293:Rifampin / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D013557:Switzerland
D004917:Erythromycin; D007538:Isoniazid; D012293:Rifampin